Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDCP.L Regulatory News (DCP)

  • There is currently no data for DCP

Directorate Change

1 May 2012 07:00

RNS Number : 4061C
Diamondcorp Plc
01 May 2012
 

1 May 2012

DiamondCorp plc

 

Directorate Change

 

The Board of Directors of DiamondCorp plc ("DiamondCorp" or "the Company") is pleased to announce the appointment of Michael Toxvaerd to the Board as Non-executive Director with immediate effect.

 

Mr Toxvaerd is Chief Investment Officer of HBG Management Partners, a leading UK private equity firm serving high net worth private and institutional clients in the Arabian Gulf. He has more than 15 years of experience founding, operating, acquiring, integrating and leading a variety of businesses in private equity and public markets at board and senior management level. Mr Toxvaerd was most recently Founder, CEO and Deputy Chairman of NeutraHealth plc, an AIM listed company. He holds an MBA from Cranfield School of Management.

 

Mr Toxvaerd is also a non-executive Director of European Islamic Investment Bank plc ("EIIB"), an AIM listed company and significant shareholder of DiamondCorp. EIIB is interested in a total of 55,761,412 ordinary shares in the Company, which represents approximately 23.02% of the issued share capital of the Company.

 

HBG Management Partners, via its wholly owned subsidiaries, is interested in 274,633,802 ordinary shares of EIIB, which represents approximately 15.55% of the issued share capital of EIIB.

 

Euan Worthington, Chairman commented:

 

"We are very pleased to welcome Michael on to the Board and believe that his financial background will help to finalise the financing for Lace while his entrepreneurial experience will help us evaluate other opportunities in the diamond sector".

 

Please see the Appendix below for further disclosure with regard to Michael Toxvaerd in accordance with the AIM Rules for Companies.

 

Contact details:

 

DiamondCorp plc

Paul Loudon, Chief Executive Officer

+44 20 3151 0970 / +27 56 212 2308

Fairfax I.S. PLC

AIM Nomad and Joint Broker

Ewan Leggat/Laura Littley

+44 207 598 5368

Ocean Equities Limited

Joint Broker

Guy Wilkes

+44 207 786 4370

PSG Capital (Pty) Limited

JSE Sponsor

John-Paul Dicks

+27 21 887 9602

Russell & Associates

Charmane Russell/Marion Brower

+27 11 880 3924

 

APPENDIX

 

Further disclosures regarding Michael Toxvaerd as required by the AIM Rules for Companies.

 

Full name: Michael Hjelm Toxvaerd

Age: 37

 

Michael Toxvaerd currently holds, or has during the five years preceding the date of this announcement held, the following directorships or partnerships: 

 

Current

Past

European Islamic Investment Bank Plc

Aquacell International Limited

HBG Holdings UK LLP

Bg2zero Ltd

HBG Small Cap 2 LTD

Biocare 2000 Limited

HBG Small Cap 3 LTD

Biocare Agricultural Supplies Limited

HBG Small Cap 4 LTD

Biocare Clinics Limited

HBG Small Cap SPV 1 Limited

Biocare (Holdings) Limited

Letssavesomemoney Limited

Biocare International Limited

PAF Ventures Limited

Biocare Limited

PAF Entertainment Limited

Brunel Healthcare Limited

Brunel Healthcare Manufacturing Limited

Natural Wellbeing Limited

Neutrahealth plc

Nutrahealth Limited

Nutrahealth UK Limited

Perrigo Pharma Limited

Totally Nourish Limited

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
BOASDWFMSFESESL
Date   Source Headline
12th May 20176:04 pmRNSCancellation of AIM Listing and Update on AltX
9th May 20175:26 pmRNSAppointment of Administrators
28th Apr 201712:15 pmRNSNotice of intention to appoint administrators
3rd Apr 20177:00 amRNSCorporate Update
28th Feb 20177:00 amRNSCorporate and Placing Update
14th Feb 20177:00 amRNSFurther Update re Placing and Corporate Update
31st Jan 20177:00 amRNSFurther Update re Placing
25th Jan 20176:31 pmRNSUpdate re Placing
20th Jan 20174:00 pmRNSResults of Placing
19th Jan 20176:20 pmRNSPlacing Update
13th Jan 20171:37 pmRNSProposed Placing, Operational and Corporate Update
19th Dec 20167:00 amRNSUpdate with Respect to Finance Facilities
13th Dec 20167:00 amRNSDirectorate Change
29th Nov 20167:00 amRNSCorporate and Operational Update
22nd Nov 20167:00 amRNSLACE UPDATE
16th Nov 20161:30 pmRNSResult of GM
16th Nov 20167:00 amRNSLACE UPDATE
14th Nov 20167:30 amRNSSuspension - Diamondcorp plc
14th Nov 20167:00 amRNSOPERATIONAL UPDATE AND SUSPENSION OF SHARES
9th Nov 20167:00 amRNSFINANCING AND OPERATIONAL UPDATE
7th Nov 20167:00 amRNSCORPORATE AND OPERATIONAL UPDATE
4th Nov 20164:27 pmRNSForm 8.3 - Diamondcorp PLC
4th Nov 201611:46 amRNSForm 8.3 - Diamondcorp Plc
3rd Nov 20164:41 pmRNSForm 8.3 - Diamondcorp PLC
3rd Nov 20163:33 pmRNSForm 8.3 - Diamond Corp plc
3rd Nov 201610:39 amRNSForm 8.3 - Diamond Corp PLC
1st Nov 20166:20 pmRNSForm 8.3 - DiamondCorp Plc
1st Nov 20163:42 pmRNSForm 8.3 - DiamondCorp PLC
1st Nov 201612:35 pmRNSForm 8.3 - Diamondcorp Plc (Amendment)
31st Oct 20166:19 pmRNSForm 8.3 - Diamondcorp Plc
31st Oct 20165:53 pmRNSForm 8.3 - Diamondcorp Plc
31st Oct 20162:09 pmPRNCorrection : Form 8 (OPD) - DiamondCorp Plc
31st Oct 20168:38 amPRNForm 8 (OPD) - DiamondCorp Plc
31st Oct 20168:35 amBUSForm 8.3 - DiamondCorp
31st Oct 20167:00 amRNSForm 8 (OPD) offeree - DiamondCorp plc
28th Oct 20165:30 pmRNSPosting of Circular and Notice of General Meeting
28th Oct 20167:00 amRNSForm 8.3 - Diamondcorp Plc
27th Oct 20166:32 pmRNSForm 8.3 - Diamondcorp Plc
27th Oct 20166:28 pmRNSForm 8.3 - Diamondcorp Plc
27th Oct 20167:00 amRNSDirectorate Change
25th Oct 20164:42 pmRNSForm 8.3 - Diamondcorp Plc
21st Oct 20167:00 amRNSRule 2.9 Announcement
20th Oct 20165:38 pmRNSForm 8.3 - Diamondcorp Plc
20th Oct 20163:00 pmRNSFinancing Facility and Board Changes
20th Oct 20162:57 pmRNSForm 8.3 - Diamoncorp
20th Oct 20162:28 pmRNSForm 8.3 - Diamondcorp
20th Oct 201610:53 amBUSForm 8.5 (EPT/RI)- DiamondCorp
20th Oct 20169:52 amRNSForm 8.3 - Diamondcorp Plc
19th Oct 20165:28 pmRNSRule 2.9 Announcement
19th Oct 20165:02 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.